Abstract
The drug manufacturer Lilly has been forced to drop one of the disorders it had previously listed for its antidepressant drug fluoxetine (Prozac), following a finding by the European drug regulator that the condition was not a well-established disease entity.
Some health researchers welcomed the regulator's decision, saying premenstrual dysphoric disorder (PMDD), which was only recently described, was an invented illness and a strong example of the medicalisation of ordinary life.
Some health researchers welcomed the regulator's decision, saying premenstrual dysphoric disorder (PMDD), which was only recently described, was an invented illness and a strong example of the medicalisation of ordinary life.
| Original language | English |
|---|---|
| Pages (from-to) | 365-365 |
| Number of pages | 1 |
| Journal | BMJ (Clinical research ed.) |
| Volume | 328 |
| Issue number | 7436 |
| DOIs | |
| Publication status | Published - 14 Feb 2004 |